How will the genotoxicity guidelines for pharmaceuticals be changed by the ICH agreement.
Sofuni
T
T
Division of Genetics and Mutagenesis, National Institute of Health Sciences, Tokyo, Japan.
D000818:Animals; D004249:DNA Damage; D004353:Drug Evaluation, Preclinical / Q000592:standards*; D064420:Drug-Related Side Effects and Adverse Reactions; D007390:International Agencies; D051379:Mice; D009152:Mutagenicity Tests / Q000592:standards*; D012958:Societies, Scientific